GlassScriptPhysician profile
Michelle Keeley
NPI 1376983247
$17,381.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $75.55 · 2021: $112 · 2022: $612 · 2023: $6,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $106.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,298.16 | 2019-2023 | Davinci Xi |
| Aspira Women'S Health INC | $264.66 | 2022 | |
| Hologic Sales and Service, LLC | $106.74 | 2019-2023 | Coolseal Generator |
| Abbvie INC. | $87.08 | 2021-2022 | |
| Organon LLC | $69.01 | 2022 | |
| Amgen INC. | $66.53 | 2019-2021 | |
| Myovant Sciences INC. | $61.06 | 2022 | |
| Therapeuticsmd, INC. | $57.19 | 2022 | |
| Sumitomo Pharma America, INC. | $47.40 | 2023 | Myfembree |
| Baxter Healthcare | $42.34 | 2019-2020 | |
| Pfizer INC. | $41.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.17 | 2019-2020 | |
| Ethicon US, LLC | $30.54 | 2019 | |
| Merck Sharp & Dohme LLC | $28.02 | 2019-2021 | |
| Smith+Nephew, INC. | $25.00 | 2023 | Pico 7 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.65 | 2020 | |
| Lilly USA, LLC | $18.62 | 2021 | |
| Minerva Surgical, INC | $17.61 | 2022 | |
| Daiichi Sankyo INC. | $15.32 | 2019 | |
| Coopersurgical, INC. | $14.30 | 2022 | |
| Glaxosmithkline, LLC. | $13.25 | 2020 | |
| Dysis Medical, INC. | $13.05 | 2021 | |
| Roche Diagnostics Corporation | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Keeley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.